查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1950453

可脫卸式彈簧圈栓塞系統市場：依輸送機制、配置、彈簧圈類型、最終用戶和應用分類－全球預測，2026-2032年

Detachable Coil Embolization System Market by Delivery Mechanism, Configuration, Coil Type, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，可脫卸彈簧圈栓塞系統市場規模將達到 13.8 億美元，到 2026 年將達到 15 億美元。預計到 2032 年，該市場規模將達到 28.5 億美元，複合年成長率為 10.85%。

關鍵市場統計數據
基準年 2025 13.8億美元
預計年份：2026年 15億美元
預測年份 2032 28.5億美元
複合年成長率 (%) 10.85%

權威地說明了可脫卸彈簧圈栓塞技術的發展歷程、臨床應用、監管促進因素及其對介入治療路徑的影響。

可脫卸式彈簧圈栓塞系統已成為介入性神經放射學和周邊血管治療的主要手段，為臨床醫生提供了動脈瘤和特定血管病變的可控栓塞方案。這些裝置旨在實現彈簧圈在目標血管內的精準定位和釋放，融合了材料科學、導管導航和釋放技術的最新進展。臨床醫生依靠彈簧圈的脫卸可靠性和結構設計來最大限度地減少手術併發症，例如彈簧圈移位、血栓性栓塞症或動脈瘤閉塞不完全。同時，醫療系統則致力於提高治療流程效率、手術吞吐量和患者預後。

醫療器材創新、臨床應用路徑、監管證據要求以及供應鏈動態的變革性變化正在重塑產業格局。

技術、臨床實務和商業策略等多面向因素的融合正在重塑可脫卸彈簧圈栓塞術的格局。脫卸機制和塗層化學技術的進步使得對釋放動力學的精確控制成為可能，從而拓展了其適應症，並提高了介入神經放射學和周邊血管專科醫師的接受度。同時，血管內治療平台和輔助器械的激增帶來了整合方面的挑戰和互通性的機遇，這些都影響著採購決策和臨床培訓重點。

對2025年關稅對製造商、供應商和臨床服務提供者的成本、採購和營運調整的連鎖反應進行分析評估

主要貿易國徵收關稅可能會透過多種管道對可拆卸線圈生態系統產生連鎖反應，因此需要為預計於2025年生效的變化製定周密的策略規劃。對零件進口、特殊合金或成品醫療設備徵收關稅將增加到岸成本，迫使製造商重新評估其籌資策略、庫存管理政策和定價技巧。為此，企業可能採取近岸外包、雙重採購或垂直整合等措施，以維持毛利率和交貨可靠性。

基於細分的關鍵洞察將終端用戶環境、脫離機制、線圈配置、臨床應用和材料技術與採用促進因素聯繫起來

詳細的細分框架闡明了臨床需求領域以及產品設計應如何與臨床工作流程相契合。基於最終用戶的採用趨勢在門診手術中心和醫院之間存在差異，而醫院又進一步細分為社區醫院和教學醫院。在這些環境中，採購選擇受手術複雜性、病例組合以及取得專業影像設備等因素驅動。門診環境優先考慮能夠實現可預測、高效手術和快速復健通訊協定的設備，而教學醫院則傾向於優先考慮適用於複雜病例和培訓需求的、功能全面且基於循證醫學的平台。

關鍵區域的區域性應用差異和供應鏈考量將影響監管策略、臨床應用和商業性優先順序。

區域趨勢透過法規結構、報銷模式、臨床基礎設施和供應商網路的差異，影響技術的推廣應用路徑。在美洲，高手術量、先進的三級醫療中心和完善的報銷機制促進了先進消融技術和新型線圈化學成分的快速應用。然而，支付方的嚴格審查和基於價值的採購策略，正日益加大對價格和療效的壓力，要求製造商證明其產品具有相對的臨床優勢和持續的性能。在歐洲、中東和非洲地區，監管時間表和醫院資金籌措的差異導致了不同的技術推廣速度。歐洲領先的醫療中心在早期採用者和循證實踐方面發揮著重要作用，而其他市場則優先考慮價格和分銷的可靠性，從而推動了分級產品供應和本地化夥伴關係。

競爭格局分析揭示了技術差異化、證據策略、夥伴關係和供應鏈韌性如何塑造供應商優勢。

可拆卸線圈領域的競爭格局取決於技術差異化、證據累積和管道執行的綜合作用。成熟的醫療設備製造商利用深厚的臨床關係、全面的培訓項目和全球分銷網路來推動產品應用，而新興企業專注於諸如新型釋放化學、先進塗層和組件幾何形狀等細分領域的創新，以吸引專家關注並積累臨床證據。契約製造製造商和精密組件供應商正日益扮演戰略合作夥伴的角色，在無需大量資本投入的情況下，實現快速原型製作和柔軟性的批量生產。

為產業領導者提供可操作的策略重點，以增強臨床應用、供應鏈韌性、證據產生和商業性差異化。

產業領導者應優先考慮切實可行的策略措施，以鞏固市場地位並支持臨床應用。首先，應投資於有針對性的臨床證據生成，以解決臨床醫生對長期封鎖持久性和再治療率的擔憂，並利用實用性註冊研究和多中心觀察性研究來補充對照試驗。這種方法將關注真實世界的臨床實踐，改善與支付方的溝通，並為比較療效的討論奠定基礎。

透明的多來源調查方法結合了深度訪談、臨床文獻綜述、監管分析和供應鏈分析，以確保獲得可靠的見解。

本分析的調查方法整合了多方面的證據，以確保其穩健性、透明度和相關性。主要研究包括對臨床醫生、採購人員、監管專家和供應鏈經理進行結構化訪談，以收集有關設備性能、推廣障礙和採購標準的第一手資料。此外，還結合了手術數據趨勢、臨床註冊摘要和匿名化的醫院採購記錄，以揭示實際使用模式和採購時間軸。

這篇綜述強調了協作式證據產生、供應鏈靈活性和客製化商業化對於確保臨床和商業性成功的重要性。

本報告整合了技術、臨床和商業性觀點，全面概述了可脫卸彈簧圈栓塞術的現狀。器材創新不斷提升脫卸精準度、彈簧圈形態和生物相容性塗層，而臨床應用則越來越依賴可驗證的真實世界療效和無縫銜接的手術流程。供應鏈和政策的變化增加了營運的複雜性，迫使製造商和醫療服務提供者尋求多元化的採購管道、實證實踐以及以服務為導向的商業模式。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 可拆卸彈簧圈栓塞系統市場（依輸送機制分類）

  • 電氣分離
    • 直流電脫附
    • 電解脫附
  • 機械可拆卸
    • 微型機械夾
    • 彈簧型

9. 可拆式彈簧圈栓塞系統市場（按類型分類）

  • 3D
    • 複雜形狀
    • J形
  • 2D
    • 螺旋
    • 直的

10. 可拆式彈簧圈栓塞系統市場（依彈簧圈類型分類）

  • 裸鉑金
  • 生物活性
  • 水凝膠塗層

第11章 可拆卸彈簧圈栓塞系統市場（以最終用戶分類）

  • 門診手術中心
  • 醫院
    • 社區醫院
    • 教學醫院

第12章 可拆卸彈簧圈栓塞系統市場（依應用領域分類）

  • 腦動脈瘤
    • 紡錘形
    • 囊狀
  • 周邊動脈瘤
    • 肢體
    • 內臟器官

13. 可拆式彈簧圈栓塞系統市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 可拆式彈簧圈栓塞系統市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各國可拆式彈簧圈栓塞系統市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

16. 美國可拆式彈簧圈栓塞系統市場

第17章 中國可脫卸彈簧圈栓塞系統市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Acandis GmbH & Co. KG
  • Asahi Intecc Co., Ltd.
  • Balt Extrusion SAS
  • Boston Scientific Corporation
  • Cerenovus, a Johnson & Johnson Company
  • Cook Medical LLC
  • Guerbet LLC
  • Integer Holdings Corporation
  • Johnson & Johnson
  • Kaneka Corporation
  • Lepu Medical Technology Co., Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • MicroVention, Inc.
  • Penumbra, Inc.
  • Shape Memory Medical, Inc.
  • Stryker Corporation
  • Terumo Corporation
Product Code: MRR-4F7A6D4FD873

The Detachable Coil Embolization System Market was valued at USD 1.38 billion in 2025 and is projected to grow to USD 1.50 billion in 2026, with a CAGR of 10.85%, reaching USD 2.85 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.38 billion
Estimated Year [2026] USD 1.50 billion
Forecast Year [2032] USD 2.85 billion
CAGR (%) 10.85%

An authoritative introduction framing detachable coil embolization technology evolution, clinical roles, regulatory drivers, and implications for interventional care pathways

Detachable coil embolization systems have become central to interventional neuroradiology and peripheral vascular care by offering clinicians controlled occlusion options for aneurysms and select vascular lesions. These devices, engineered to enable precise placement and detachment of coils within target vasculature, bridge advances in material science, catheter navigation, and detachment technologies. Clinicians rely on detachment reliability and coil configuration to minimize procedural complications such as coil migration, thromboembolism, or incomplete aneurysm occlusion, while health systems focus on pathway efficiency, procedural throughput, and patient outcomes.

Over recent years, design iteration has centered on optimizing coil conformability, radiopacity, and thrombogenic profiles to address a wider range of lesion morphologies and access routes. Regulatory expectations and reimbursement dynamics have driven manufacturers to invest in robust clinical evidence and post-market surveillance. As a result, stakeholders from device engineers to hospital procurement leaders are recalibrating adoption strategies based on procedural performance, operator learning curves, and compatibility with existing catheter platforms. This introduction frames the remainder of the analysis by situating device-level technical evolution within clinical decision-making, regulatory oversight, and supply chain considerations that collectively shape adoption pathways.

Transformative shifts in device innovation, clinical adoption pathways, regulatory evidence expectations, and supply chain dynamics that are redefining the industry landscape

The landscape for detachable coil embolization is being reshaped by convergent forces that span technology, clinical practice, and commercial strategy. Advances in detachment mechanisms and coating chemistries are enabling finer control of deployment dynamics, and this is translating into expanded procedural indications and greater acceptance among neurointerventionalists and peripheral specialists. Simultaneously, the proliferation of endovascular platforms and adjunctive devices is prompting integration challenges and opportunities for interoperability, thereby influencing procurement decisions and clinical training priorities.

Another transformative shift is the migration of certain procedures to lower-acuity settings, driven by improvements in device safety profiles and streamlined peri-procedural pathways. This transition is affecting case mix, capital allocation, and reimbursement negotiation. Payor and regulatory scrutiny is concurrently increasing the emphasis on demonstrable real-world outcomes and cost-effectiveness, which in turn places a premium on robust clinical registries and post-market evidence generation. Lastly, supply chain digitization, modular manufacturing approaches, and partnerships between established suppliers and nimble innovators are accelerating product iteration cycles, making speed-to-clinic and strategic alliances decisive competitive factors.

Analytical assessment of how 2025 tariff measures could propagate cost, sourcing, and operational adjustments across manufacturers, suppliers, and clinical providers

The introduction of tariff measures by major trading economies can reverberate across the detachable coil ecosystem through multiple transmission channels, and anticipated changes effective in 2025 warrant careful strategic planning. Tariffs applied to component imports, specialized alloys, or finished medical devices can increase landed costs, prompting manufacturers to reassess sourcing strategies, inventory policies, and pricing approaches. In response, firms may pursue nearshoring, dual sourcing, or vertical integration to preserve gross margins and delivery reliability.

Beyond direct cost effects, tariffs can alter supplier negotiations and lead times, creating incentives to redesign products for alternative material inputs or to qualify additional contract manufacturers. Clinical operations may feel the impact through delayed deliveries or higher unit costs, which could affect procurement cycles and hospital budgeting decisions. In parallel, regulatory compliance and customs clearance processes may require additional documentation and auditing, raising administrative overhead. Strategic responses that have emerged include supply chain mapping to identify tariff exposure, scenario planning to evaluate cost pass-through versus absorption, and accelerated supplier qualification programs to diversify risk and maintain continuity of supply.

Key segmentation-driven insights that connect end-user settings, detachment mechanics, coil configurations, clinical applications, and material technologies to adoption drivers

A granular segmentation framework clarifies where clinical demand concentrates and how product design must align with clinical workflows. Based on end user, adoption dynamics differ between Ambulatory Surgery Centers and Hospitals, with hospitals further differentiated into Community Hospitals and Teaching Hospitals; procedural complexity, case mix, and access to specialized imaging guide procurement choices across these settings. Ambulatory environments prioritize devices that enable predictable, efficient procedures and rapid recovery protocols, while teaching hospitals often prioritize versatility and evidence-based platforms suited for complex cases and training needs.

Based on delivery mechanism, clinical expectations hinge on detachment reliability and handling characteristics. Electrodetachable and Mechanical Detachable approaches present distinct user experiences, with electrodetachable technologies subdividing into DC Electrodetachment and Electrolytic Detachment variants that influence detachment timing and energy profiles, while mechanical detachable systems further divide into Micromechanical Clip and Spring Loaded architectures that prioritize tactile feedback and mechanical predictability. These distinctions shape operator preference and procedural setup.

Based on configuration, device geometry dictates conformability and lesion coverage. Three D and Two D geometries address different aneurysm morphologies, with Three D configurations further described as Complex Shape and J Shape to accommodate irregular sac anatomy, while Two D options including Helical and Straight designs optimize packing density and longitudinal control. Matching configuration to aneurysm architecture remains central to minimizing recurrence risk.

Based on application, clinical segmentation separates Cerebral Aneurysm and Peripheral Aneurysm use cases; cerebral indications are further categorized into Fusiform and Saccular lesions requiring divergent treatment philosophies, and peripheral applications split into Extremity and Visceral targets that pose different access and embolization challenges. Finally, based on coil type, materials strategy spans Bare Platinum, Bioactive, and Hydrogel Coated coils, each offering unique thrombogenic properties and interaction with healing biology. Integrating these segmentation layers enables more nuanced product positioning, clinical training programs, and procurement specifications designed to meet differentiated clinical needs.

Regional adoption nuances and supply chain considerations across major geographies that influence regulatory strategy, clinical uptake, and commercial prioritization

Regional dynamics shape adoption pathways through differences in regulatory frameworks, reimbursement models, clinical infrastructure, and supplier networks. In the Americas, high procedural volumes, developed tertiary care centers, and established reimbursement mechanisms support rapid uptake of advanced detachment technologies and novel coil chemistries; however, payor scrutiny and value-based purchasing are increasing pressure on price and outcomes, incentivizing manufacturers to demonstrate comparative clinical benefit and durable performance. In Europe, Middle East & Africa, heterogeneity in regulatory timelines and hospital funding creates a patchwork of adoption speeds; leading European centers often act as early adopters and evidence generators, while other markets emphasize affordability and distribution reliability, prompting tiered product offerings and local partnerships.

Across Asia-Pacific, expansive population bases, rising investment in interventional capabilities, and growing numbers of trained specialists are expanding the addressable base for detachable coils, although infrastructure variability means product strategies must accommodate a range of hospital capabilities and procurement models. Manufacturers and suppliers must tailor regulatory strategies, clinical training, and commercial engagement to the specific reimbursement and hospital procurement realities of each region, while also anticipating cross-border supply chain considerations that affect lead times and pricing competitiveness.

Competitive landscape analysis revealing how technological differentiation, evidence strategies, partnerships, and supply chain resilience are shaping supplier advantage

Competitive dynamics in the detachable coil space are defined by a combination of technological differentiation, evidence generation, and channel execution. Established medical device manufacturers leverage deep clinical relationships, comprehensive training programs, and global distribution networks to drive adoption, while emerging companies focus on niche innovation-such as novel detachment chemistries, advanced coatings, or configuration geometries-to capture specialist interest and create clinical proof points. Contract manufacturers and precision component suppliers are increasingly strategic partners, enabling faster prototyping and volume flexibility without significant capital expenditure.

Strategic partnerships between device developers and imaging or navigation platform providers are strengthening integrated procedural workflows, improving clinician confidence, and accelerating adoption in centers seeking streamlined solutions. Meanwhile, service models that include comprehensive training, procedural support, and outcomes tracking are proving decisive in high-stakes neurovascular procedures. Commercially, firms that align reimbursement policy support with clinician education and that invest in real-world evidence collection are better positioned to negotiate formulary placement and long-term institutional usage. Finally, supply chain resilience-characterized by diversified sourcing, responsive logistics, and regulatory compliance expertise-remains a core capability that separates reliable suppliers from more fragile entrants.

Actionable strategic priorities for industry leaders to strengthen clinical adoption, supply chain resilience, evidence generation, and commercial differentiation

Industry leaders should prioritize a set of actionable strategic moves to fortify market position and support clinical adoption. First, invest in targeted clinical evidence generation that addresses operator concerns around long-term occlusion durability and re-treatment rates, using pragmatic registries and multi-center observational studies to complement controlled trials. This approach improves payer conversations and informs comparative effectiveness discussions while being responsive to real-world practice.

Second, accelerate supply chain diversification by qualifying alternative suppliers for critical components and by developing contingency stock strategies for high-use items. Near-term actions include mapping supplier concentration risks, stress-testing logistics under tariff scenarios, and establishing rapid qualification pathways for secondary manufacturers. Third, refine product portfolios to offer clear segmentation-aligned platforms: devices tailored to ambulatory settings should emphasize ease-of-use and procedural efficiency, while offerings for teaching hospitals should prioritize versatility and training compatibility. Fourth, deepen clinical engagement through interdisciplinary training programs and simulation-based credentialing that reduce operator variability and improve clinical outcomes. Lastly, align commercial models with value-based purchasing by providing bundled service offerings that combine devices, training, and outcomes tracking to reduce institutional barriers to adoption and demonstrate tangible return on investment.

Transparent, multi-source research methodology combining primary interviews, clinical literature review, regulatory analysis, and supply chain mapping to ensure robust insights

The research methodology underpinning this analysis integrates multiple evidence streams to ensure robustness, transparency, and relevance. Primary research included structured interviews with clinicians, procurement leaders, regulatory experts, and supply chain managers to capture first-hand perspectives on device performance, adoption barriers, and purchasing criteria. These insights were supplemented by procedural data trends, clinical registry summaries, and anonymized hospital sourcing logs to illuminate real-world usage patterns and procurement timelines.

Secondary research encompassed regulatory filings, peer-reviewed clinical literature, patent landscapes, and manufacturing technology briefs to chart innovation trajectories and compliance considerations. Data validation relied on triangulation across sources, cross-checking interview findings with clinical publications and regulatory documentation. Supply chain analysis used bill-of-material mapping and logistics assessments to identify tariff exposure and supplier concentration risk. The methodology emphasized reproducibility through clear documentation of data sources, interview protocols, and assumptions underpinning qualitative judgments, enabling stakeholders to interrogate and adapt the findings to their specific contexts.

Concluding synthesis emphasizing the need for coordinated evidence generation, supply chain agility, and tailored commercialization to secure clinical and commercial success

This report synthesizes technical, clinical, regulatory, and commercial perspectives to present an integrated view of the detachable coil embolization landscape. Device innovation continues to advance detachment precision, coil morphology, and biocompatible coatings, while clinical adoption increasingly depends on demonstrable real-world outcomes and seamless procedural integration. Supply chain and policy shifts are adding layers of operational complexity, prompting manufacturers and providers to pursue diversified sourcing, evidence-based engagement, and service-oriented commercial models.

Looking forward, stakeholders that combine disciplined clinical evidence generation with pragmatic supply chain strategies and tailored product segmentation will be best positioned to navigate an evolving environment. Collaboration between device developers, clinical leaders, and procurement teams will be essential to align device capabilities with procedural needs and institutional constraints. The conclusion underscores the importance of adaptive strategies that balance innovation with operational resilience and a commitment to improving patient outcomes across diverse care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Detachable Coil Embolization System Market, by Delivery Mechanism

  • 8.1. Electrodetachable
    • 8.1.1. DC Electrodetachment
    • 8.1.2. Electrolytic Detachment
  • 8.2. Mechanical Detachable
    • 8.2.1. Micromechanical Clip
    • 8.2.2. Spring Loaded

9. Detachable Coil Embolization System Market, by Configuration

  • 9.1. Three D
    • 9.1.1. Complex Shape
    • 9.1.2. J Shape
  • 9.2. Two D
    • 9.2.1. Helical
    • 9.2.2. Straight

10. Detachable Coil Embolization System Market, by Coil Type

  • 10.1. Bare Platinum
  • 10.2. Bioactive
  • 10.3. Hydrogel Coated

11. Detachable Coil Embolization System Market, by End User

  • 11.1. Ambulatory Surgery Centers
  • 11.2. Hospitals
    • 11.2.1. Community Hospitals
    • 11.2.2. Teaching Hospitals

12. Detachable Coil Embolization System Market, by Application

  • 12.1. Cerebral Aneurysm
    • 12.1.1. Fusiform
    • 12.1.2. Saccular
  • 12.2. Peripheral Aneurysm
    • 12.2.1. Extremity
    • 12.2.2. Visceral

13. Detachable Coil Embolization System Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Detachable Coil Embolization System Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Detachable Coil Embolization System Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Detachable Coil Embolization System Market

17. China Detachable Coil Embolization System Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Acandis GmbH & Co. KG
  • 18.6. Asahi Intecc Co., Ltd.
  • 18.7. Balt Extrusion S.A.S.
  • 18.8. Boston Scientific Corporation
  • 18.9. Cerenovus, a Johnson & Johnson Company
  • 18.10. Cook Medical LLC
  • 18.11. Guerbet LLC
  • 18.12. Integer Holdings Corporation
  • 18.13. Johnson & Johnson
  • 18.14. Kaneka Corporation
  • 18.15. Lepu Medical Technology Co., Ltd.
  • 18.16. Medtronic plc
  • 18.17. Merit Medical Systems, Inc.
  • 18.18. MicroPort Scientific Corporation
  • 18.19. MicroVention, Inc.
  • 18.20. Penumbra, Inc.
  • 18.21. Shape Memory Medical, Inc.
  • 18.22. Stryker Corporation
  • 18.23. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CONFIGURATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DC ELECTRODETACHMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DC ELECTRODETACHMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DC ELECTRODETACHMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTROLYTIC DETACHMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTROLYTIC DETACHMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTROLYTIC DETACHMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MICROMECHANICAL CLIP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MICROMECHANICAL CLIP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MICROMECHANICAL CLIP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SPRING LOADED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SPRING LOADED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SPRING LOADED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COMPLEX SHAPE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COMPLEX SHAPE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COMPLEX SHAPE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY J SHAPE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY J SHAPE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY J SHAPE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HELICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HELICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HELICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY STRAIGHT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY STRAIGHT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY STRAIGHT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BARE PLATINUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BARE PLATINUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BARE PLATINUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BIOACTIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BIOACTIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BIOACTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROGEL COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROGEL COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROGEL COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TEACHING HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TEACHING HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TEACHING HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY FUSIFORM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY FUSIFORM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY FUSIFORM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SACCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SACCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SACCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY EXTREMITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY EXTREMITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY EXTREMITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY VISCERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY VISCERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY VISCERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 208. GCC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. GCC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 210. GCC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 211. GCC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 212. GCC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 213. GCC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, 2018-2032 (USD MILLION)
  • TABLE 214. GCC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, 2018-2032 (USD MILLION)
  • TABLE 215. GCC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. GCC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. GCC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 218. GCC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. GCC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 220. GCC DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 247. G7 DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 248. G7 DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 249. G7 DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 250. G7 DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 251. G7 DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 252. G7 DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, 2018-2032 (USD MILLION)
  • TABLE 253. G7 DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, 2018-2032 (USD MILLION)
  • TABLE 254. G7 DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. G7 DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. G7 DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 257. G7 DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 258. G7 DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 259. G7 DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 260. NATO DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 261. NATO DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 262. NATO DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 263. NATO DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 264. NATO DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 265. NATO DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, 2018-2032 (USD MILLION)
  • TABLE 266. NATO DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, 2018-2032 (USD MILLION)
  • TABLE 267. NATO DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. NATO DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. NATO DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 270. NATO DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 271. NATO DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 272. NATO DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 273. GLOBAL DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED STATES DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY THREE D, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TWO D, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED STATES DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED STATES DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED STATES DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED STATES DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL ANEURYSM, 2018-2032 (USD MILLION)
  • TABLE 287. CHINA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 288. CHINA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DELIVERY MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 289. CHINA DETACHABLE COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTRODETACHABLE, 2018-2032 (USD MILLIO